GrippeCanadaV3, Main, Exploration, bibRecord, 000051

Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.

Identifieur interne : 000051 ( Main/Exploration ); précédent : 000050; suivant : 000052

Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.

Auteurs : Andrew Stewart [Canada] ; Otto G. Vanderkooi [Canada] ; Raylene A. Reimer [Canada] ; Patricia K. Doyle-Baker [Canada]

Source :

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme [ 1715-5320 ] ; 2018.

RBID : pubmed:29481760

Descripteurs français

KwdFr :
- Absorptiométrie photonique, Adiposité, Adolescent, Adulte, Alberta, Anticorps antiviraux (sang), Aptitude physique, Facteurs de l'âge, Facteurs sexuels, Facteurs temps, Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (virologie), Humains, Immunogénicité des vaccins, Jeune adulte, Mâle, Projets pilotes, Saisons, Séroconversion, Vaccination, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Volontaires sains, Études prospectives.
MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Grippe humaine, Vaccins antigrippaux.
- sang : Anticorps antiviraux.
- virologie : Grippe humaine.
- Absorptiométrie photonique, Adiposité, Adolescent, Adulte, Alberta, Aptitude physique, Facteurs de l'âge, Facteurs sexuels, Facteurs temps, Grippe humaine, Humains, Immunogénicité des vaccins, Jeune adulte, Mâle, Projets pilotes, Saisons, Séroconversion, Vaccination, Volontaires sains, Études prospectives.

English descriptors

KwdEn :
- Absorptiometry, Photon, Adiposity, Adolescent, Adult, Age Factors, Alberta, Antibodies, Viral (blood), Healthy Volunteers, Humans, Immunogenicity, Vaccine, Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (prevention & control), Influenza, Human (virology), Male, Physical Fitness, Pilot Projects, Prospective Studies, Seasons, Seroconversion, Sex Factors, Time Factors, Vaccination, Young Adult.
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Influenza Vaccines.
- immunology : Influenza, Human.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Absorptiometry, Photon, Adiposity, Adolescent, Adult, Age Factors, Alberta, Healthy Volunteers, Humans, Immunogenicity, Vaccine, Male, Physical Fitness, Pilot Projects, Prospective Studies, Seasons, Seroconversion, Sex Factors, Time Factors, Vaccination, Young Adult.

Abstract

During the 2009 H1N1 pandemic, individuals with obesity were disproportionately affected by H1N1 with increased levels of mortality and morbidity. This led to questions regarding the potential impact of lifestyle on the effectiveness of immunization. Currently, the research is limited on influenza vaccination and the associated changes in immune response with body composition and physical activity. The purpose of this pilot study was to investigate the potential role of adiposity and physical activity in the immune response elicited by the 2014/2015 seasonal trivalent influenza vaccine. A prospective cohort study examining the 2014/2015 seasonal trivalent influenza vaccine was conducted by collecting baseline and 4-week postvaccination fasting blood samples from 45 male Albertans between the ages of 18 and 35 years. Percent body fat (%BF) was assessed through dual X-ray absorptiometry imagining and physical activity through self-reported survey scores. While no differences in median %BF were associated with seroconversion rates in participants, the median physical activity score was higher among those that did not seroconvert to the vaccine. Significant differences were found for the A/Texas strain (p < 0.01) and a similar trend of lower magnitude observed for the remaining 2 influenza strains. These results suggest that higher physical activity levels may influence immune response to vaccination and that assessing factors beyond those commonly used can be of value when identifying vaccine response in the population.

DOI: 10.1139/apnm-2017-0683
PubMed: 29481760

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000054
to stream Main, to step Curation: 000054

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.</title>
<author><name sortKey="Stewart, Andrew" sort="Stewart, Andrew" uniqKey="Stewart A" first="Andrew" last="Stewart">Andrew Stewart</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vanderkooi, Otto G" sort="Vanderkooi, Otto G" uniqKey="Vanderkooi O" first="Otto G" last="Vanderkooi">Otto G. Vanderkooi</name>
<affiliation wicri:level="4"><nlm:affiliation>b Departments of Paediatrics, Pathology & Laboratory Medicine, Microbiology & Infectious diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b Departments of Paediatrics, Pathology & Laboratory Medicine, Microbiology & Infectious diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reimer, Raylene A" sort="Reimer, Raylene A" uniqKey="Reimer R" first="Raylene A" last="Reimer">Raylene A. Reimer</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>c Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>c Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doyle Baker, Patricia K" sort="Doyle Baker, Patricia K" uniqKey="Doyle Baker P" first="Patricia K" last="Doyle-Baker">Patricia K. Doyle-Baker</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>d Faculty of Environmental Design, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>d Faculty of Environmental Design, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29481760</idno>
<idno type="pmid">29481760</idno>
<idno type="doi">10.1139/apnm-2017-0683</idno>
<idno type="wicri:Area/Main/Corpus">000054</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000054</idno>
<idno type="wicri:Area/Main/Curation">000054</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000054</idno>
<idno type="wicri:Area/Main/Exploration">000054</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.</title>
<author><name sortKey="Stewart, Andrew" sort="Stewart, Andrew" uniqKey="Stewart A" first="Andrew" last="Stewart">Andrew Stewart</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vanderkooi, Otto G" sort="Vanderkooi, Otto G" uniqKey="Vanderkooi O" first="Otto G" last="Vanderkooi">Otto G. Vanderkooi</name>
<affiliation wicri:level="4"><nlm:affiliation>b Departments of Paediatrics, Pathology & Laboratory Medicine, Microbiology & Infectious diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b Departments of Paediatrics, Pathology & Laboratory Medicine, Microbiology & Infectious diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reimer, Raylene A" sort="Reimer, Raylene A" uniqKey="Reimer R" first="Raylene A" last="Reimer">Raylene A. Reimer</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>c Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>c Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doyle Baker, Patricia K" sort="Doyle Baker, Patricia K" uniqKey="Doyle Baker P" first="Patricia K" last="Doyle-Baker">Patricia K. Doyle-Baker</name>
<affiliation wicri:level="4"><nlm:affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>d Faculty of Environmental Design, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>d Faculty of Environmental Design, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4</wicri:regionArea>
<orgName type="university">Université de Calgary</orgName>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme</title>
<idno type="eISSN">1715-5320</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Absorptiometry, Photon</term>
<term>Adiposity</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Alberta</term>
<term>Antibodies, Viral (blood)</term>
<term>Healthy Volunteers</term>
<term>Humans</term>
<term>Immunogenicity, Vaccine</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Physical Fitness</term>
<term>Pilot Projects</term>
<term>Prospective Studies</term>
<term>Seasons</term>
<term>Seroconversion</term>
<term>Sex Factors</term>
<term>Time Factors</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Absorptiométrie photonique</term>
<term>Adiposité</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Alberta</term>
<term>Anticorps antiviraux (sang)</term>
<term>Aptitude physique</term>
<term>Facteurs de l'âge</term>
<term>Facteurs sexuels</term>
<term>Facteurs temps</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains</term>
<term>Immunogénicité des vaccins</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Projets pilotes</term>
<term>Saisons</term>
<term>Séroconversion</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Volontaires sains</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Absorptiometry, Photon</term>
<term>Adiposity</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Alberta</term>
<term>Healthy Volunteers</term>
<term>Humans</term>
<term>Immunogenicity, Vaccine</term>
<term>Male</term>
<term>Physical Fitness</term>
<term>Pilot Projects</term>
<term>Prospective Studies</term>
<term>Seasons</term>
<term>Seroconversion</term>
<term>Sex Factors</term>
<term>Time Factors</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Absorptiométrie photonique</term>
<term>Adiposité</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Alberta</term>
<term>Aptitude physique</term>
<term>Facteurs de l'âge</term>
<term>Facteurs sexuels</term>
<term>Facteurs temps</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Immunogénicité des vaccins</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Projets pilotes</term>
<term>Saisons</term>
<term>Séroconversion</term>
<term>Vaccination</term>
<term>Volontaires sains</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">During the 2009 H1N1 pandemic, individuals with obesity were disproportionately affected by H1N1 with increased levels of mortality and morbidity. This led to questions regarding the potential impact of lifestyle on the effectiveness of immunization. Currently, the research is limited on influenza vaccination and the associated changes in immune response with body composition and physical activity. The purpose of this pilot study was to investigate the potential role of adiposity and physical activity in the immune response elicited by the 2014/2015 seasonal trivalent influenza vaccine. A prospective cohort study examining the 2014/2015 seasonal trivalent influenza vaccine was conducted by collecting baseline and 4-week postvaccination fasting blood samples from 45 male Albertans between the ages of 18 and 35 years. Percent body fat (%BF) was assessed through dual X-ray absorptiometry imagining and physical activity through self-reported survey scores. While no differences in median %BF were associated with seroconversion rates in participants, the median physical activity score was higher among those that did not seroconvert to the vaccine. Significant differences were found for the A/Texas strain (p < 0.01) and a similar trend of lower magnitude observed for the remaining 2 influenza strains. These results suggest that higher physical activity levels may influence immune response to vaccination and that assessing factors beyond those commonly used can be of value when identifying vaccine response in the population.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29481760</PMID>
<DateCompleted><Year>2018</Year>
<Month>11</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1715-5320</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>43</Volume>
<Issue>8</Issue>
<PubDate><Year>2018</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme</Title>
<ISOAbbreviation>Appl Physiol Nutr Metab</ISOAbbreviation>
</Journal>
<ArticleTitle>Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.</ArticleTitle>
<Pagination><MedlinePgn>769-774</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1139/apnm-2017-0683</ELocationID>
<Abstract><AbstractText>During the 2009 H1N1 pandemic, individuals with obesity were disproportionately affected by H1N1 with increased levels of mortality and morbidity. This led to questions regarding the potential impact of lifestyle on the effectiveness of immunization. Currently, the research is limited on influenza vaccination and the associated changes in immune response with body composition and physical activity. The purpose of this pilot study was to investigate the potential role of adiposity and physical activity in the immune response elicited by the 2014/2015 seasonal trivalent influenza vaccine. A prospective cohort study examining the 2014/2015 seasonal trivalent influenza vaccine was conducted by collecting baseline and 4-week postvaccination fasting blood samples from 45 male Albertans between the ages of 18 and 35 years. Percent body fat (%BF) was assessed through dual X-ray absorptiometry imagining and physical activity through self-reported survey scores. While no differences in median %BF were associated with seroconversion rates in participants, the median physical activity score was higher among those that did not seroconvert to the vaccine. Significant differences were found for the A/Texas strain (p < 0.01) and a similar trend of lower magnitude observed for the remaining 2 influenza strains. These results suggest that higher physical activity levels may influence immune response to vaccination and that assessing factors beyond those commonly used can be of value when identifying vaccine response in the population.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vanderkooi</LastName>
<ForeName>Otto G</ForeName>
<Initials>OG</Initials>
<AffiliationInfo><Affiliation>b Departments of Paediatrics, Pathology & Laboratory Medicine, Microbiology & Infectious diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Reimer</LastName>
<ForeName>Raylene A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>c Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Doyle-Baker</LastName>
<ForeName>Patricia K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo><Affiliation>a Human Performance Lab, Faculty of Kinesiology, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>d Faculty of Environmental Design, University of Calgary, 2500 University Dr. NW, Calgary, AB T2N 1N4, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>02</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>Appl Physiol Nutr Metab</MedlineTA>
<NlmUniqueID>101264333</NlmUniqueID>
<ISSNLinking>1715-5312</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050154" MajorTopicYN="Y">Adiposity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000416" MajorTopicYN="N">Alberta</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071497" MajorTopicYN="Y">Immunogenicity, Vaccine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010809" MajorTopicYN="Y">Physical Fitness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000069078" MajorTopicYN="N">Seroconversion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">activité physique</Keyword>
<Keyword MajorTopicYN="N">adiposity</Keyword>
<Keyword MajorTopicYN="N">adiposité</Keyword>
<Keyword MajorTopicYN="N">influenza</Keyword>
<Keyword MajorTopicYN="N">jeunes hommes</Keyword>
<Keyword MajorTopicYN="N">physical activity</Keyword>
<Keyword MajorTopicYN="N">vaccination</Keyword>
<Keyword MajorTopicYN="N">young men</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>11</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29481760</ArticleId>
<ArticleId IdType="doi">10.1139/apnm-2017-0683</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Alberta</li>
</region>
<settlement><li>Calgary</li>
</settlement>
<orgName><li>Université de Calgary</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Alberta"><name sortKey="Stewart, Andrew" sort="Stewart, Andrew" uniqKey="Stewart A" first="Andrew" last="Stewart">Andrew Stewart</name>
</region>
<name sortKey="Doyle Baker, Patricia K" sort="Doyle Baker, Patricia K" uniqKey="Doyle Baker P" first="Patricia K" last="Doyle-Baker">Patricia K. Doyle-Baker</name>
<name sortKey="Doyle Baker, Patricia K" sort="Doyle Baker, Patricia K" uniqKey="Doyle Baker P" first="Patricia K" last="Doyle-Baker">Patricia K. Doyle-Baker</name>
<name sortKey="Reimer, Raylene A" sort="Reimer, Raylene A" uniqKey="Reimer R" first="Raylene A" last="Reimer">Raylene A. Reimer</name>
<name sortKey="Reimer, Raylene A" sort="Reimer, Raylene A" uniqKey="Reimer R" first="Raylene A" last="Reimer">Raylene A. Reimer</name>
<name sortKey="Vanderkooi, Otto G" sort="Vanderkooi, Otto G" uniqKey="Vanderkooi O" first="Otto G" last="Vanderkooi">Otto G. Vanderkooi</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000051 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000051 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29481760
   |texte=   Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29481760" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.

Immune response in highly active young men to the 2014/2015 seasonal influenza vaccine.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki